Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
13
0
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Actualities in Procedural Sedation: Remimazolam
Role: collaborator
The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting
Role: lead
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements
Role: lead
Postoperative Delirium in the ICU Setting of an Eastern European Centre
Role: lead
Contrast-enhanced vs. B-mode Ultrasound-guided Percutaneous Biopsy of Retroperitoneal Tumors
Role: collaborator
New Biomarkers in the Intracystic Liquid of Inflammatory and Non-inflammatory Pancreatic Cysts
Role: collaborator
CH-EUS in Diagnosis of Inoperable Bile Duct Tumors
Role: lead
Comparison of Two High Performance Guidewires in ERCP
Role: collaborator
Anesthesia and Postoperative Outcome in Colorectal Cancer Patients
Role: lead
The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma
Role: collaborator
Elucidation of the Mechanisms and Effects of Certain Anesthetic Interventions on Digestive Cancer Patients Subjected to Surgery
Role: collaborator
Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery
Role: lead
Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions
Role: collaborator
All 13 trials loaded